IDH1 and astrocytoma (excluding glioblastoma): In contrast, WHO grade 3 was present in 71 (43.4%) cases of IDH mutant and 1p/19q codeleted oligodendrogliomas and 101 (40.1%) cases of IDH mutant astrocytomas.